CNClinicalTrials.govClinical trialNot applicableRecruiting
Protective Mechanisms of Phycocyanin in Partial Hepatectomy-Associated Liver Injury
Official record
- Identifier
NCT07760038- Recruiting locations
country
China- Interventions studied
- PhycocyaninMaltodextrin
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Target enrolment
- 30 participants
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Status
- Recruiting
- First posted
- Aug 12, 2026
- Last updated on the registry
- Aug 12, 2026
- Age
- 18 Years – 75 Years
- Sex
- ALL
- Study contact
- The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.
- Eligibility criteria
Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.
Inclusion Criteria: * Diagnosis of intrahepatic cholangiocarcinoma * Child-Pugh class A liver function * Planned neoadjuvant treatment with gemcitabine plus oxaliplatin, lenvatinib, and a PD-1 inhibitor * Planned anatomical hemihepatectomy with an expected future liver remnant greater than 40% * Age 18 to 75 years * Willing and able to participate and provide written informed consent * No acute illness or significant worsening of symptoms within 4 weeks before enrollment Exclusion Criteria: * Serious coexisting medical conditions * Known allergy to phycocyanin * Other malignant tumors * Previous liver resection * History of severe psychiatric illness that may affect treatment adherence
- Indexed under
- Liver Cancer